200 related articles for article (PubMed ID: 38195117)
1. CLN3 deficiency leads to neurological and metabolic perturbations during early development.
Heins-Marroquin U; Singh RR; Perathoner S; Gavotto F; Merino Ruiz C; Patraskaki M; Gomez-Giro G; Kleine Borgmann F; Meyer M; Carpentier A; Warmoes MO; Jäger C; Mittelbronn M; Schwamborn JC; Cordero-Maldonado ML; Crawford AD; Schymanski EL; Linster CL
Life Sci Alliance; 2024 Mar; 7(3):. PubMed ID: 38195117
[TBL] [Abstract][Full Text] [Related]
2. Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis.
Gomez-Giro G; Arias-Fuenzalida J; Jarazo J; Zeuschner D; Ali M; Possemis N; Bolognin S; Halder R; Jäger C; Kuper WFE; van Hasselt PM; Zaehres H; Del Sol A; van der Putten H; Schöler HR; Schwamborn JC
Acta Neuropathol Commun; 2019 Dec; 7(1):222. PubMed ID: 31888773
[TBL] [Abstract][Full Text] [Related]
3. CLN3 is required for the clearance of glycerophosphodiesters from lysosomes.
Laqtom NN; Dong W; Medoh UN; Cangelosi AL; Dharamdasani V; Chan SH; Kunchok T; Lewis CA; Heinze I; Tang R; Grimm C; Dang Do AN; Porter FD; Ori A; Sabatini DM; Abu-Remaileh M
Nature; 2022 Sep; 609(7929):1005-1011. PubMed ID: 36131016
[TBL] [Abstract][Full Text] [Related]
4. Glycerophosphodiesters inhibit lysosomal phospholipid catabolism in Batten disease.
Nyame K; Hims A; Aburous A; Laqtom NN; Dong W; Medoh UN; Heiby JC; Xiong J; Ori A; Abu-Remaileh M
Mol Cell; 2024 Apr; 84(7):1354-1364.e9. PubMed ID: 38447580
[TBL] [Abstract][Full Text] [Related]
5. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
[TBL] [Abstract][Full Text] [Related]
6. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
Drack AV; Miller JN; Pearce DA
J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
[TBL] [Abstract][Full Text] [Related]
7. Gene correction of the CLN3 c.175G>A variant in patient-derived induced pluripotent stem cells prevents pathological changes in retinal organoids.
Zhang X; Zhang D; Thompson JA; Chen SC; Huang Z; Jennings L; McLaren TL; Lamey TM; De Roach JN; Chen FK; McLenachan S
Mol Genet Genomic Med; 2021 Mar; 9(3):e1601. PubMed ID: 33497524
[TBL] [Abstract][Full Text] [Related]
8. Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.
Zhong Y; Mohan K; Liu J; Al-Attar A; Lin P; Flight RM; Sun Q; Warmoes MO; Deshpande RR; Liu H; Jung KS; Mitov MI; Lin N; Butterfield DA; Lu S; Liu J; Moseley HNB; Fan TWM; Kleinman ME; Wang QJ
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165883. PubMed ID: 32592935
[TBL] [Abstract][Full Text] [Related]
9. A novel in-frame mutation in
Sher M; Farooq M; Abdullah U; Ali Z; Faryal S; Zakaria M; Ullah F; Bukhari H; Møller RS; Tommerup N; Baig SM
Int J Neurosci; 2019 Sep; 129(9):890-895. PubMed ID: 30892110
[No Abstract] [Full Text] [Related]
10. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
[TBL] [Abstract][Full Text] [Related]
11. Modulating membrane fluidity corrects Batten disease phenotypes in vitro and in vivo.
Schultz ML; Tecedor L; Lysenko E; Ramachandran S; Stein CS; Davidson BL
Neurobiol Dis; 2018 Jul; 115():182-193. PubMed ID: 29660499
[TBL] [Abstract][Full Text] [Related]
12. Antigen presenting cell abnormalities in the Cln3(-/-) mouse model of juvenile neuronal ceroid lipofuscinosis.
Hersrud SL; Kovács AD; Pearce DA
Biochim Biophys Acta; 2016 Jul; 1862(7):1324-36. PubMed ID: 27101989
[TBL] [Abstract][Full Text] [Related]
13. Deterioration of visual quality and acuity as the first sign of ceroid lipofuscinosis type 3 (CLN3), a rare neurometabolic disease.
Purzycka-Olewiecka JK; Hetmańczyk-Sawicka K; Kmieć T; Szczęśniak D; Trubicka J; Krawczyński M; Pronicki M; Ługowska A
Metab Brain Dis; 2023 Feb; 38(2):709-715. PubMed ID: 36576693
[TBL] [Abstract][Full Text] [Related]
14. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
[TBL] [Abstract][Full Text] [Related]
15. Altered flurothyl seizure induction latency, phenotype, and subsequent mortality in a mouse model of juvenile neuronal ceroid lipofuscinosis/batten disease.
Kriscenski-Perry E; Applegate CD; Serour A; Mhyre TR; Leonardo CC; Pearce DA
Epilepsia; 2002 Oct; 43(10):1137-40. PubMed ID: 12366726
[TBL] [Abstract][Full Text] [Related]
16. Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3 gene.
Sondhi D; Scott EC; Chen A; Hackett NR; Wong AM; Kubiak A; Nelvagal HR; Pearse Y; Cotman SL; Cooper JD; Crystal RG
Hum Gene Ther; 2014 Mar; 25(3):223-39. PubMed ID: 24372003
[TBL] [Abstract][Full Text] [Related]
17. A novel role of the Batten disease gene CLN3: association with BMP synthesis.
Hobert JA; Dawson G
Biochem Biophys Res Commun; 2007 Jun; 358(1):111-6. PubMed ID: 17482562
[TBL] [Abstract][Full Text] [Related]
18. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
Chan CH; Mitchison HM; Pearce DA
Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
[TBL] [Abstract][Full Text] [Related]
19. Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration.
Wiley LA; Burnight ER; Drack AV; Banach BB; Ochoa D; Cranston CM; Madumba RA; East JS; Mullins RF; Stone EM; Tucker BA
Hum Gene Ther; 2016 Oct; 27(10):835-846. PubMed ID: 27400765
[TBL] [Abstract][Full Text] [Related]
20. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
